Loading…
Loading grant details…
| Funder | NATIONAL CANCER INSTITUTE |
|---|---|
| Recipient Organization | University of Michigan At Ann Arbor |
| Country | United States |
| Start Date | Jan 01, 2024 |
| End Date | Dec 31, 2028 |
| Duration | 1,826 days |
| Number of Grantees | 2 |
| Roles | Co-Investigator; Principal Investigator |
| Data Source | NIH (US) |
| Grant ID | 10798426 |
Peripheral T-cell lymphomas (PTCL), derived from mature T cells, are aggressive malignancies for which existing therapies are suboptimal, as the median overall survival of patients with relapsed/refractory disease is
University of Michigan At Ann Arbor
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant